Literature DB >> 24855191

Splicing factor mutations in AML.

Seishi Ogawa1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24855191     DOI： 10.1182/blood-2014-04-566752

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells.

Authors:  Bernadette A Chua; Inge Van Der Werf; Catriona Jamieson; Robert A J Signer
Journal:  Cell Stem Cell       Date:  2020-02-06       Impact factor: 24.633

2.  Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.

Authors:  Ke Chen; Haibing Xiao; Jin Zeng; Gan Yu; Hui Zhou; Chunhua Huang; Weimin Yao; Wei Xiao; Junhui Hu; Wei Guan; Lily Wu; Jiaoti Huang; Qihong Huang; Hua Xu; Zhangqun Ye
Journal:  Clin Cancer Res       Date:  2016-11-22       Impact factor: 12.531

3.  Proteogenomic analysis prioritises functional single nucleotide variants in cancer samples.

Authors:  Shiyong Ma; Ranjeeta Menon; Rebecca C Poulos; Jason W H Wong
Journal:  Oncotarget       Date:  2017-09-27

Review 4.  Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features.

Authors:  Valeria Visconte; Megan O Nakashima; Heesun J Rogers
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.